Linking evidence for targeted blood biomarkers in post-stroke cognitive impairment and dementia
With improvements in acute stroke treatment and more patients surving the acute stroke period, the identification and prognostication of post-stroke disability is paramount. Post-stroke cognitive impairment and dementia (PSCID) severely impacts the morbidity and mortality of stroke survivors. While...
Saved in:
Main Authors: | Jinny Hong, Katherine Mun, Kyle C. Kern, Marissa Thirion, Jason D. Hinman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Stroke |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fstro.2024.1491542/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
When Stroke Disguises as Dementia: A Case of Missed Cerebral Venous Thrombosis
by: Tina Moghadam Fard, et al.
Published: (2025-01-01) -
Plasma fibrinogen as a potential biomarker of cognitive impairment after acute ischemic stroke
by: Chunxiao Wei, et al.
Published: (2024-12-01) -
Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study
by: Si Nae Oh, et al.
Published: (2024-10-01) -
Association of a multiplex immune marker panel with incident cognitive impairment and dementia: The Northern Manhattan Study
by: Mohammad Abdurrehman Sheikh, et al.
Published: (2025-02-01) -
Healthcare Workers (HCWs)’ Perceptions and Current Practice of Managing Cognitively Impaired Patients with Chronic Obstructive Pulmonary Disease (COPD)
by: Rayan A. Siraj
Published: (2025-01-01)